JRJoanne Rovet

Joanne Rovet

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Joanne Rovet has a total of 16 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Targeting the Manifestations of Subclinical and Overt Hypothyroidism Within the Hippocampus

    by Joanne F Rovet

    Background: The past decade has witnessed a surge of articles describing the neurocognitive sequelae and associated structural and functional brain abnormalities of patients with overt hypothyroidism (OH) and subclinical hypothyroidism (SCH). Findings show effects primarily within the frontal lobes with usually worse outcomes for OH than SCH. Several recent studies have also indicated hypothyroid patients may have smaller hippocampi, a key structure for memory. Context: The JCEM paper by Zhang and colleagues applies 2 novel approaches for analyzing hippocampal structure and function. One uses an automated processing tool that segments the hippocampus into distinct subregions, and the other performs connectivity analysis to assess the relationships between specific hippocampal subregions and cortical areas. Relatively large samples of OH and SCH patients and healthy controls received a test of global cognitive functioning and underwent structural and functional magnetic resonance imaging. Results showed hypothyroid groups scored significantly below controls on the memory scale and also had smaller hippocampal volumes in selective subregions. Effects were stronger for SCH than OH groups, who also showed different patterns of interconnectivity between hippocampal subregions and specific frontal lobe areas. Interpretation: To make sense of these findings, I explored the rodent and human literatures on thyroid hormone's role in hippocampal functioning and on hippocampal subfields and their purported functions and interconnections. Because current results suggest SCH may represent a distinct clinical entity with unique brain manifestations, I hypothesized 2 explanations for these findings, one involving transporter defects in the brain barriers and the other, differential neurodegeneration of the blood-brain barrier vascular unit.


    • 4 March 2013
      • Vol. 20  (1) , e44-52

    Towards identifying a characteristic neuropsychological profile for fetal alcohol spectrum disorders. 1. Analysis of the Motherisk FASD clinic.

    by Kelly Nash, Sara Stevens, Joanne Rovet, Ellen Fantus, Irena Nulman, Donna Sorbara, Gideon Koren

    Children with FASD display a heterogeneous profile and may have deficits in physical, behavioural, emotional, and social functioning, as the result of prenatal alcohol exposure. The major objective of the current study was to identify if a specific pattern of neuropsychological functioning exists among children prenatally exposed to alcohol who received a diagnosis, versus exposed children who did not. We compared groups on domains of intellectual functioning, memory, attention, executive functioning, motor functioning, language/communication and achievement. One hundred and seventy children who were seen in the clinic between 2005 and 2009 were included in this study. Out of the total 170 children seen, 109 received an FASD diagnosis. We identified a specific neuropsychological profile that typifies children diagnosed with an FASD versus those exposed prenatally to alcohol, who did not receive a diagnosis. Diagnosed children displayed a neuropsychological profile characterized by weaknesses in the areas of verbal reasoning, memory, overall language functioning, math reasoning and calculation. Groups did not differ on measures of attention or executive functioning. The information gained from these analyses, are essential for informing best practices for diagnosis and treatment.


    • 5 September 2011
      • Vol. 18  (3) , e440-53

    A differential approach for examining the behavioural phenotype of fetal alcohol spectrum disorders.

    by Kelly Nash, Gideon Koren, Joanne Rovet

    In 2006, Nash and colleagues published results suggesting that individual items from the Child Behavior Checklist (CBCL) could be used as a screening tool that was highly sensitive in differentiating children with FASD from controls and children with Attention Deficit Hyperactivity Disorder (ADHD). Since many of the items referred to features of Oppositional Defiant/Conduct Disorder (ODD/CD), it was not clear whether the items reflected comorbidity with ODD/CD, or were unique to children with FASD. The present study sought to replicate the results of our 2006 paper using a new and larger sample, which also includes a group of children diagnosed with ODD/CD. Retrospective psychological chart review was conducted on 56 children with FASD, 50 with ADHD, 60 with ODD/CD, and 50 normal control (NC) children. Receiver operating characteristic curve (ROC) analysis of CBCL items discriminating FASD from NC was used to compare FASD to the ADHD and ODD/CD groups. ROC analyses showed scores of a) 3 or higher on 10 items differentiated FASD from NC with a sensitivity of 98%, specificity of 42% and b) 2 or higher on 5 items reflecting oppositional behaviors differentiated FASD from ADHD with a sensitivity of 89% and specificity of 42%. Our findings partially replicate the results of our 2006 study and additionally elucidate the behavioural differences between children with FASD and those with ODD/CD. The proposed screening tool is currently the only tool available that is empirically derived and able to differentiate children with FASD from children with clinically similar profiles.


  • Visual Abilities at 6 Months in Preterm Infants: Impact of Thyroid Hormone Deficiency and Neonatal Medical Morbidity

    by Nevena Simic, Carol Westall, Elizabeth V. Astzalos, Joanne Rovet

    Preterm infants are at risk for neonatal morbidity, transiently reduced thyroid hormone (TH) levels, and impaired visual abilities. To determine the interrelationship between these factors, we measured TH levels in the period ex utero and compared their visual abilities with those of term infants at 6 months (corrected) of age. The preterm group consisted of 62 infants stratified by gestational age: Group A (23-26 weeks, n = 10), Group B (27-29 weeks, n = 23), Group C (30-32 weeks, n = 19), and Group D (33-35 weeks, n = 10). Controls were 31 healthy full-term infants. In the preterm group, free thyroxine, triiodothyronine, and thyroid-stimulating hormone levels were measured at 2 and 4 weeks of life and 40 weeks postconceptional age. All infants were assessed for visual acuity, contrast sensitivity, and color vision using electrophysiological techniques. Compared with controls, the preterm infants demonstrated reduced contrast sensitivity at low temporal frequencies and slower blue-yellow color processing. Groups did not differ from controls in visual acuity. In the preterm group, reduced contrast sensitivity and slow blue-yellow and red-green color vision processing were associated with low TH levels, low gestational age, and several medical morbidities. Our findings signify that some of the weak visual abilities in preterm infants can be accounted for, in part, by their reduced TH levels in the early postnatal period.